We've found
						2,414
						 archived clinical trials in
						Overactive Bladder
					
				We've found
						2,414
						 archived clinical trials in
						Overactive Bladder
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
	
	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
	
Updated: 10/31/2012
  
  
  	  A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Trial In Overactive Bladder Subjects To Confirm The Efficacy Of 8 Mg Fesoterodine Compared To 4 Mg Fesoterodine.
		Status: Enrolling	
	Updated: 10/31/2012
Click here to add this to my saved trials
		    
		 
	  	
	A Single Dose Study of the Pharmacokinetics of MK-4618 in Participants With Renal Insufficiency (MK-4618-014 AM1)
	
Updated: 11/6/2012
  
  
  An Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-4618 in Patients With Renal Insufficiency
		Status: Enrolling	
	Updated: 11/6/2012
	
	A Single Dose Study of the Pharmacokinetics of MK-4618 in Participants With Renal Insufficiency (MK-4618-014 AM1)
	
Updated: 11/6/2012
  
  
  	  An Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-4618 in Patients With Renal Insufficiency
		Status: Enrolling	
	Updated: 11/6/2012
Click here to add this to my saved trials
		    
		 
	  	
	A Single Dose Study of the Pharmacokinetics of MK-4618 in Participants With Renal Insufficiency (MK-4618-014 AM1)
	
Updated: 11/6/2012
  
  
  An Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-4618 in Patients With Renal Insufficiency
		Status: Enrolling	
	Updated: 11/6/2012
	
	A Single Dose Study of the Pharmacokinetics of MK-4618 in Participants With Renal Insufficiency (MK-4618-014 AM1)
	
Updated: 11/6/2012
  
  
  	  An Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-4618 in Patients With Renal Insufficiency
		Status: Enrolling	
	Updated: 11/6/2012
Click here to add this to my saved trials
		    
		 
	  	
	A Single Dose Study of the Pharmacokinetics of MK-4618 in Participants With Renal Insufficiency (MK-4618-014 AM1)
	
Updated: 11/6/2012
  
  
  An Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-4618 in Patients With Renal Insufficiency
		Status: Enrolling	
	Updated: 11/6/2012
	
	A Single Dose Study of the Pharmacokinetics of MK-4618 in Participants With Renal Insufficiency (MK-4618-014 AM1)
	
Updated: 11/6/2012
  
  
  	  An Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-4618 in Patients With Renal Insufficiency
		Status: Enrolling	
	Updated: 11/6/2012
Click here to add this to my saved trials
		    
		 
	  	
	Rigid Versus Flexible Cystoscopy in Women
	
Updated: 11/19/2012
  
  
  Rigid Versus Flexible Cystoscopy in Women in Outpatient Clinic
		Status: Enrolling	
	Updated: 11/19/2012
	
	Rigid Versus Flexible Cystoscopy in Women
	
Updated: 11/19/2012
  
  
  	  Rigid Versus Flexible Cystoscopy in Women in Outpatient Clinic
		Status: Enrolling	
	Updated: 11/19/2012
Click here to add this to my saved trials
		    
		 
	  	
	Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
	
		Status: Enrolling	
	
Updated: 12/19/2012
  
  
  Updated: 12/19/2012
	
	Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
	
		Status: Enrolling	
	
Updated: 12/19/2012
  
  
  	  Updated: 12/19/2012
Click here to add this to my saved trials
		    
		 
	  	
	Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
	
		Status: Enrolling	
	
Updated: 12/19/2012
  
  
  Updated: 12/19/2012
	
	Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
	
		Status: Enrolling	
	
Updated: 12/19/2012
  
  
  	  Updated: 12/19/2012
Click here to add this to my saved trials
		    
		 
	  	
	Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate
	
Updated: 1/10/2013
  
  
  Prospective Randomized Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate
		Status: Enrolling	
	Updated: 1/10/2013
	
	Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate
	
Updated: 1/10/2013
  
  
  	  Prospective Randomized Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate
		Status: Enrolling	
	Updated: 1/10/2013
Click here to add this to my saved trials
		    
		 
	  	
	A Study of the Pharmacokinetics and Pharmacodynamics of MK4618 in Women With Overactive Bladder (MK-4618-004 AM1)
	
Updated: 2/8/2013
  
  
  A Placebo and Active-Comparator Controlled Multiple-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of MK-4618 in Patients With Overactive Bladder
		Status: Enrolling	
	Updated: 2/8/2013
	
	A Study of the Pharmacokinetics and Pharmacodynamics of MK4618 in Women With Overactive Bladder (MK-4618-004 AM1)
	
Updated: 2/8/2013
  
  
  	  A Placebo and Active-Comparator Controlled Multiple-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of MK-4618 in Patients With Overactive Bladder
		Status: Enrolling	
	Updated: 2/8/2013
Click here to add this to my saved trials
		    
		 
	  	
	A Study of the Pharmacokinetics and Pharmacodynamics of MK4618 in Women With Overactive Bladder (MK-4618-004 AM1)
	
Updated: 2/8/2013
  
  
  A Placebo and Active-Comparator Controlled Multiple-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of MK-4618 in Patients With Overactive Bladder
		Status: Enrolling	
	Updated: 2/8/2013
	
	A Study of the Pharmacokinetics and Pharmacodynamics of MK4618 in Women With Overactive Bladder (MK-4618-004 AM1)
	
Updated: 2/8/2013
  
  
  	  A Placebo and Active-Comparator Controlled Multiple-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of MK-4618 in Patients With Overactive Bladder
		Status: Enrolling	
	Updated: 2/8/2013
Click here to add this to my saved trials
		    
		 
	  	
	VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate
	
Updated: 3/6/2013
  
  
  A Pilot Study to Assess the Safety and Efficacy of Solifenacin (VESIcare) for Improving Urinary and Bladder Functions in Patients Undergoing Radiation Therapy of the Prostate
		Status: Enrolling	
	Updated: 3/6/2013
	
	VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate
	
Updated: 3/6/2013
  
  
  	  A Pilot Study to Assess the Safety and Efficacy of Solifenacin (VESIcare) for Improving Urinary and Bladder Functions in Patients Undergoing Radiation Therapy of the Prostate
		Status: Enrolling	
	Updated: 3/6/2013
Click here to add this to my saved trials
		    
		 
	  	
	VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate
	
Updated: 3/6/2013
  
  
  A Pilot Study to Assess the Safety and Efficacy of Solifenacin (VESIcare) for Improving Urinary and Bladder Functions in Patients Undergoing Radiation Therapy of the Prostate
		Status: Enrolling	
	Updated: 3/6/2013
	
	VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate
	
Updated: 3/6/2013
  
  
  	  A Pilot Study to Assess the Safety and Efficacy of Solifenacin (VESIcare) for Improving Urinary and Bladder Functions in Patients Undergoing Radiation Therapy of the Prostate
		Status: Enrolling	
	Updated: 3/6/2013
Click here to add this to my saved trials
		    
		 
	  	
	3D Ultrasound in Women With Vacuum or Forceps Deliveries
	
Updated: 3/29/2013
  
  
  3-Dimension Ultrasound Findings in Women Who Have Undergone Vacuum Versus Forceps-Assisted Vaginal Deliveries
		Status: Enrolling	
	Updated: 3/29/2013
	
	3D Ultrasound in Women With Vacuum or Forceps Deliveries
	
Updated: 3/29/2013
  
  
  	  3-Dimension Ultrasound Findings in Women Who Have Undergone Vacuum Versus Forceps-Assisted Vaginal Deliveries
		Status: Enrolling	
	Updated: 3/29/2013
Click here to add this to my saved trials
		    
		 
	  	
	A Single-Dose Study of the Pharmacokinetics of MK-4618 in Patients With Hepatic Insufficiency (MK-4618-013)
	
Updated: 4/10/2013
  
  
  A Two-Part, Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-4618 in Patients With Hepatic Insufficiency
		Status: Enrolling	
	Updated: 4/10/2013
	
	A Single-Dose Study of the Pharmacokinetics of MK-4618 in Patients With Hepatic Insufficiency (MK-4618-013)
	
Updated: 4/10/2013
  
  
  	  A Two-Part, Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-4618 in Patients With Hepatic Insufficiency
		Status: Enrolling	
	Updated: 4/10/2013
Click here to add this to my saved trials
		    
		 
	  	
	Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling
	
Updated: 6/25/2013
  
  
  Randomized Controlled Trial Examining the Return of Urinary Continence After Robot-assisted Radical Prostatectomy With or Without a Urethrovesical Sling
		Status: Enrolling	
	Updated: 6/25/2013
	
	Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling
	
Updated: 6/25/2013
  
  
  	  Randomized Controlled Trial Examining the Return of Urinary Continence After Robot-assisted Radical Prostatectomy With or Without a Urethrovesical Sling
		Status: Enrolling	
	Updated: 6/25/2013
Click here to add this to my saved trials
		    
		 
	  	
	Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling
	
Updated: 6/25/2013
  
  
  Randomized Controlled Trial Examining the Return of Urinary Continence After Robot-assisted Radical Prostatectomy With or Without a Urethrovesical Sling
		Status: Enrolling	
	Updated: 6/25/2013
	
	Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling
	
Updated: 6/25/2013
  
  
  	  Randomized Controlled Trial Examining the Return of Urinary Continence After Robot-assisted Radical Prostatectomy With or Without a Urethrovesical Sling
		Status: Enrolling	
	Updated: 6/25/2013
Click here to add this to my saved trials
		    
		 
	  	
	Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling
	
Updated: 6/25/2013
  
  
  Randomized Controlled Trial Examining the Return of Urinary Continence After Robot-assisted Radical Prostatectomy With or Without a Urethrovesical Sling
		Status: Enrolling	
	Updated: 6/25/2013
	
	Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling
	
Updated: 6/25/2013
  
  
  	  Randomized Controlled Trial Examining the Return of Urinary Continence After Robot-assisted Radical Prostatectomy With or Without a Urethrovesical Sling
		Status: Enrolling	
	Updated: 6/25/2013
Click here to add this to my saved trials
		    
		 
	  	
	Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease
	
Updated: 6/26/2013
  
  
  Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease: A Randomized, Double-blind, Crossover Pilot Study
		Status: Enrolling	
	Updated: 6/26/2013
	
	Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease
	
Updated: 6/26/2013
  
  
  	  Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease: A Randomized, Double-blind, Crossover Pilot Study
		Status: Enrolling	
	Updated: 6/26/2013
Click here to add this to my saved trials
		    
		 
	  	
	Comparison of Motor and Sensory Response With Interstim Stimulation
	
Updated: 7/18/2013
  
  
  Comparison of Motor and Sensory Response With Interstim Stimulation for Overactive Bladder and Urgency-Frequency Syndrome
		Status: Enrolling	
	Updated: 7/18/2013
	
	Comparison of Motor and Sensory Response With Interstim Stimulation
	
Updated: 7/18/2013
  
  
  	  Comparison of Motor and Sensory Response With Interstim Stimulation for Overactive Bladder and Urgency-Frequency Syndrome
		Status: Enrolling	
	Updated: 7/18/2013
Click here to add this to my saved trials
		    
		 
	  